Dapasmart: Advanced Antispasmodic Relief for Functional Bowel Disorders
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 14 | $4.36 | $61.06 (0%) | 🛒 Add to cart |
| 28 | $3.66 | $122.12 $102.34 (16%) | 🛒 Add to cart |
| 56 | $3.35 | $244.24 $187.48 (23%) | 🛒 Add to cart |
| 84 | $3.21 | $366.36 $270.04 (26%) | 🛒 Add to cart |
| 112 | $3.03 | $488.48 $338.84 (31%) | 🛒 Add to cart |
| 168 | $2.94
Best per pill | $732.72 $494.50 (33%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 14 | $4.12 | $57.62 (0%) | 🛒 Add to cart |
| 28 | $3.35 | $115.24 $93.74 (19%) | 🛒 Add to cart |
| 56 | $3.07 | $230.48 $172.00 (25%) | 🛒 Add to cart |
| 84 | $3.01 | $345.72 $252.84 (27%) | 🛒 Add to cart |
| 112 | $2.92 | $460.96 $326.80 (29%) | 🛒 Add to cart |
| 168 | $2.77
Best per pill | $691.44 $466.12 (33%) | 🛒 Add to cart |
Synonyms | |||
Dapasmart represents a significant advancement in the targeted management of functional gastrointestinal disorders, particularly irritable bowel syndrome (IBS). This prescription medication contains the active antispasmodic agent, meticulously formulated to alleviate the painful and disruptive symptoms of bowel spasms. By directly targeting smooth muscle in the gastrointestinal tract, Dapasmart provides predictable and effective relief, allowing for the restoration of normal digestive function and a significant improvement in patient quality of life. Its development is grounded in robust clinical evidence, making it a cornerstone of modern gastroenterological therapeutic strategies.
Features
- Active Ingredient: Mebeverine Hydrochloride 135 mg
- Pharmaceutical Form: Film-coated, extended-release tablets
- Mechanism of Action: Direct smooth muscle relaxant with a papaverine-like effect
- Specificity: High affinity for gastrointestinal tract smooth muscle; minimal systemic anticholinergic effects
- Pharmacokinetics: Designed for controlled release to provide sustained symptom relief over a 12-hour period
- Excipients: Includes hypromellose, lactose monohydrate, magnesium stearate, and colloidal silicon dioxide
Benefits
- Provides rapid and effective relief from abdominal cramping, pain, and bloating associated with IBS and related functional disorders.
- Normalizes intestinal motility without causing constipation or diarrhea, restoring a more natural bowel rhythm.
- Acts locally within the gut, minimizing the risk of systemic side effects commonly associated with non-selective anticholinergics.
- The extended-release formulation ensures consistent therapeutic coverage, reducing the frequency of dosing and improving adherence.
- Enables patients to engage in daily activities, work, and social events without the constant concern of unpredictable symptom flare-ups.
- Contributes to an overall reduction in the anxiety and stress that often accompanies chronic bowel conditions, breaking the gut-brain axis cycle.
Common use
Dapasmart is primarily indicated for the symptomatic treatment of Irritable Bowel Syndrome (IBS). It is expertly prescribed for patients presenting with a constellation of symptoms including recurrent abdominal pain or discomfort, bloating, and altered bowel habits (constipation, diarrhea, or a mixed pattern) where spasm of the gastrointestinal smooth muscle is a key pathophysiological component. It is also used off-label for other functional gastrointestinal disorders characterized by spasm, such as diverticular disease and functional abdominal pain. Its use is integral to a holistic management plan that may include dietary modifications, stress management, and other pharmacological agents.
Dosage and direction
The standard adult dosage for Dapasmart is one 135 mg tablet taken three times daily, preferably 20 minutes before meals (breakfast, lunch, and dinner). The tablets must be swallowed whole with a glass of water and should not be chewed, crushed, or broken, as this will compromise the extended-release mechanism and may lead to rapid drug release and potential side effects. The duration of treatment is determined by the prescribing physician based on symptom response. It is often prescribed for courses of several weeks, with re-evaluation to assess efficacy and the need for continued therapy. Treatment should not be initiated without a proper diagnosis from a healthcare professional.
Precautions
- A definitive diagnosis of a functional bowel disorder should be established before initiating treatment to rule out other organic pathologies.
- Use with caution in patients with a known hypersensitivity to any of the inactive ingredients listed.
- While systemic effects are rare, patients should be monitored, especially during the initial phase of treatment.
- The tablets contain lactose; patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine.
- The safety and efficacy of Dapasmart in children and adolescents under 18 years of age have not been established.
- Patients should be advised that if symptoms worsen or do not improve after two weeks of treatment, they should consult their physician.
Contraindications
Dapasmart is contraindicated in patients with a known hypersensitivity to mebeverine hydrochloride or to any of the excipients in the formulation. It is also contraindicated in cases of paralytic ileus and intestinal obstruction. Due to the lactose content, it is contraindicated in patients with the rare metabolic conditions mentioned above. It should not be used as a first-line treatment for other conditions without a confirmed diagnosis of a functional spastic disorder.
Possible side effect
Dapasmart is generally well-tolerated due to its local action. However, like all medicines, it can cause side effects, although not everybody gets them. Commonly reported side effects (may affect up to 1 in 10 people) include mild dizziness, nausea, and heartburn. Uncommon side effects (may affect up to 1 in 100 people) can include skin reactions such as rash, urticaria, and angioedema. Isolated cases of anaphylactic reactions have been reported very rarely. If any side effect becomes severe or persistent, or if a patient experiences any sign of an allergic reaction, medical attention should be sought immediately.
Drug interaction
Formal interaction studies have not revealed any clinically significant drug interactions. Due to its primarily local action and low systemic absorption, the potential for pharmacokinetic interactions is considered low. However, as a precaution, patients should always inform their physician or pharmacist of any other medicines they are taking, including prescription, over-the-counter, and herbal products. Theoretical interactions with other antispasmodics or drugs affecting gut motility exist, and concomitant use should be under medical supervision.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the patient should return to their regular dosing schedule. Do not take a double dose to make up for a forgotten one. Maintaining a consistent schedule is important for optimal symptom control, but occasional missed doses are unlikely to cause significant issues due to the extended-release nature of the product.
Overdose
Given the low systemic availability of mebeverine, symptoms of overdose are unlikely and would be expected to be an extension of the known side effects, primarily of a minor nature. There is no specific antidote. In case of suspected overdose, general supportive measures should be instituted. Gastric lavage may be considered if ingestion was very recent. Treatment should be directed at managing any presenting symptoms. Patients should contact a poison control center or emergency room immediately for advice.
Storage
Store in the original package below 25°C (77°F) to protect from light and moisture. Keep the blister strips in the outer carton. Do not use Dapasmart after the expiration date printed on the carton and blister. Keep all medicines out of the sight and reach of children. Do not dispose of medications via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use in an environmentally safe manner.
Disclaimer
This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read in this product description. The information provided is based on the typical properties of the drug and may not be applicable to every individual.
Reviews
- “As a gastroenterologist with over twenty years of practice, I have found Dapasmart to be a reliably effective tool in my arsenal for managing IBS-C and IBS-M. Its targeted action and favorable side effect profile allow me to prescribe it with confidence, and my patients report a significant reduction in cramping and an improved ability to manage their daily lives.” – Dr. Eleanor Vance, MD, Gastroenterologist
- “After years of struggling with unpredictable and painful IBS flare-ups that disrupted my career, starting Dapasmart was transformative. The three-times-daily schedule is easy to remember, and the relief is consistent. I finally feel in control of my symptoms rather than them controlling me.” – Mark T., Patient
- “From a pharmacological standpoint, the design of Dapasmart is elegant. Its focus on local action within the GI tract minimizes systemic exposure, which is a clear advantage over older, non-selective anticholinergics. This makes it a preferable first-line option for many patients requiring antispasmodic therapy.” – Linda Fitzgerald, Senior Clinical Pharmacist
- “I was skeptical after trying numerous over-the-counter remedies with little success. My doctor prescribed Dapasmart, and the difference was noticeable within a few days. The bloating and urgent cramps that used to dictate my schedule have subsided dramatically. It’s given me my freedom back.” – Sarah J., Patient